Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-10-03

Clinical Trial Update: Olanzapine Anorexia Cachexia [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluating olanzapine for anorexia in cachexia. The update notes the study status but does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Cairo University | Conditions: Anorexia | Phase 3 | Status: COMPLETED